Market Research Logo

Phylogica Limited - Product Pipeline Review - 2015

Phylogica Limited - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Phylogica Limited - Product Pipeline Review - 2015’, provides an overview of the Phylogica Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Phylogica Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Phylogica Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Phylogica Limited’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Phylogica Limited’s pipeline products
Reasons to buy
  • Evaluate Phylogica Limited’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Phylogica Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Phylogica Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Phylogica Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Phylogica Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Phylogica Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Phylogica Limited Snapshot
Phylogica Limited Overview
Key Information
Key Facts
Phylogica Limited - Research and Development Overview
Key Therapeutic Areas
Phylogica Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Phylogica Limited - Pipeline Products Glance
Phylogica Limited - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Phylogica Limited - Drug Profiles
PYC-35
Product Description
Mechanism of Action
R&D Progress
PYC-36
Product Description
Mechanism of Action
R&D Progress
PYC-38
Product Description
Mechanism of Action
R&D Progress
PYC-98
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide for Gram-Negative Bacterial Infection
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Multi-Drug Resistant Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit c-Myc for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit CD40-Ligand for Autoimmune Disorders, Rheumatoid Arthritis and Inflammation
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit N-Myc for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit STAT3 for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit STAT5 for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Inhibit YB-1 for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptides to Inhibit SOX18 for Cancer
Product Description
Mechanism of Action
R&D Progress
Phylogica Limited - Pipeline Analysis
Phylogica Limited - Pipeline Products by Target
Phylogica Limited - Pipeline Products by Molecule Type
Phylogica Limited - Pipeline Products by Mechanism of Action
Phylogica Limited - Dormant Projects
Phylogica Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Phylogica Limited, Key Information
Phylogica Limited, Key Facts
Phylogica Limited - Pipeline by Indication, 2015
Phylogica Limited - Pipeline by Stage of Development, 2015
Phylogica Limited - Monotherapy Products in Pipeline, 2015
Phylogica Limited - Preclinical, 2015
Phylogica Limited - Discovery, 2015
Phylogica Limited - Pipeline by Target, 2015
Phylogica Limited - Pipeline by Molecule Type, 2015
Phylogica Limited - Pipeline Products by Mechanism of Action, 2015
Phylogica Limited - Dormant Developmental Projects,2015
Phylogica Limited, Other Locations
Phylogica Limited, Subsidiaries
List of Figures
Phylogica Limited - Pipeline by Top 10 Indication, 2015
Phylogica Limited - Pipeline by Stage of Development, 2015
Phylogica Limited - Monotherapy Products in Pipeline, 2015
Phylogica Limited - Pipeline by Top 10 Target, 2015
Phylogica Limited - Pipeline by Top 10 Molecule Type, 2015
Phylogica Limited - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report